We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Progressive Dig | LSE:PRO | London | Ordinary Share | GB00B87ZTG26 | ORD 1/14P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 240.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/11/2005 15:33 | Well - won't they need to inform if family,relative buy, obviously unless they have other illegal ways | mali7 | |
22/11/2005 15:22 | Can't directors buy now? Who knows, maybe their wives and children have done so...:-) | siegesmunduk | |
22/11/2005 15:20 | Well, the bid is 1.75p, but I am getting 2.02p with price improver.... | wikroberts | |
22/11/2005 14:56 | Hint of ASD interest on III discussion board... | shirtless dan | |
22/11/2005 14:38 | P E Bream (gfd) 2 Mar 2005 P +100,000 @ 5.75p £5,750 221,462 F A Harding* (ch) 2 Mar 2005 P +100,000 @ 5.75p £5,750 366,058 Dr P L Gould 2 Mar 2005 P +100,000 @ 5.75p £5,750 450,689 Can't directors buy now? | mali7 | |
22/11/2005 14:37 | Shareholder Information - November 2005 Major Shareholders YGGDRASIL AB 58, 505, 984 (16.13%) SCHRODER INVESTMENT MANAGEMENT 38, 828, 800 (10.70%) BARCLAYS STOCKBROKERS LIMITED 26, 323, 126 (7.26%) WATERHOUSE SECURITIES 20, 695, 864 (5.70%) COMDIRECT 17, 136, 963 (4.72%) HALIFAX SHARE DEALING 11, 184, 197 (3.08%) 2005 AGM 1st December 05 ??? Then we should get news/updates then - not long to go! | mali7 | |
22/11/2005 14:32 | The spread on my quotes is 1.92 - 2.24p...hopefully we will see 2p bid today. | wikroberts | |
22/11/2005 14:08 | I have seen many sell recomendation and the opposite happening to the share price and I have seen many buy recomendation and the opposite happening to the share price SO DYOR and follow the opposite direction of what everyone else does, so hopefully you will be the single winner while the majority always lose! | mali7 | |
22/11/2005 13:54 | We are now 23% up, just wonder how many people were caught by opening short positions after IC sell recommendation last friday. | wikroberts | |
22/11/2005 13:33 | The consultants would say - there are no problems, merely opportunities. Perhaps looking at suitability for new assays??? | shirtless dan | |
22/11/2005 11:23 | Agree Consultants are expensive - have been one myself. However good to get that independent eyes and their report will an interest to everyone involved with Provalis (investores, banks, emploeeys etc). Hope fully they will answer: What needs to be fixed? How will it be fixed? How long will it take? What additional capital is needed? Will it bring good ROI? etc But if anyone knew these answeres - he/she would either remortgage their house to purchase all shares possible at this price OR dump all shares they had for anything the market would give. Latest recomendation: Speculative buy up to 3p. (until furhter news) Always DYOR. | mali7 | |
22/11/2005 10:46 | A worrying feature of the RNS last week is the need of external consultants to fix IN2IT problems. CAN'T THESE BE FIXED IN HOUSE? | toledo100 | |
22/11/2005 10:25 | Sorry forgot to mention - One M buy trade for 100,000 @ 1.75p. Anyway are we expecting any announcement soon - how long can they take to inform us? | mali7 | |
22/11/2005 10:21 | up 10.8% I think downwards journey was as interesting as the upwards journey is - agree? | mali7 | |
22/11/2005 08:54 | wikroberts - MM's filling a big order perhaps? (ever hopeful!) | shirtless dan | |
22/11/2005 08:41 | Just checked the quotes for online trading, maximum I can get through Barclays is 20K at 1.75p, but to sell 300K at 1.6p.... I agree that currently it is difficult to value the company, as we don't know what they are likely to get for their pharmaceutical business and what are the problems with in2it, but the fact that there wasn't any substantial selling following last weeks news is pretty obvious now.... | wikroberts | |
22/11/2005 08:37 | I predicted that Woodford would in his initial statement bring out some skeletons - and the market response has been severe but not unexpected. The assessment may be to understand the performance of the device for new assays, and to tackle manufacturing quality issues. It doesn't mean the device is necessarily flawed. | shirtless dan | |
22/11/2005 08:33 | To state undervalue at this point in time is ludicrous. Not even the directors can estimate value with any certainty,hence the review. | alibongo612 | |
22/11/2005 08:21 | Shirtless----- On what basis can you state the co. is undervalued. Everyone who wants to sleep at night should be out of Pro quicker than Roy Keane was at ManU.There is no confidence at any level either in Pro or outsiders looking at Pro | rabbrooks | |
21/11/2005 16:59 | this could be and this is only my opinion of a classic pump and dump | fatgreek | |
21/11/2005 16:30 | I think rumors that it would be suspended Monday morning had an effect on last weeks decline, hopefully that was the bottom - until further announcement. | mali7 | |
21/11/2005 16:28 | Remember: in2it(TM)A1c did achieve NGSP Certification and Brand Creation Award So it is a working product, but seems management has been rushing it to sell to get quick cash, but faced with teething problems. (I think in2it does have some value, if not I happy to take the product and it's patent free - and set up my own factory in Asia - to later sell cheaply!) - just joking! | mali7 | |
21/11/2005 16:25 | Still, I can sell online 200K at 1.6p and buy only 20K at 1.75p.... | wikroberts | |
21/11/2005 16:17 | It seems now that MMs did not get expected stock at 1p or below and now have to balance their books.... | wikroberts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions